Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Anthem, Cigna shareholders approve Merger as Antitrust Hurdles Await

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Haemonetics Wins FDA Approval for Vascade...

Haemonetics has secured an expanded regulatory milestone in the...

FDA Clears Medtronic Stealth Axis for...

Medtronic’s Stealth Axis FDA clearance marks an expansion of...

Philips AI DeviceGuide Gets FDA Approval...

Regulatory clearance has been secured by Philips from the...
Shareholders of Anthem (ANTM) and Cigna (CI) approved by overwhelming margins the merger of the two health plans into the nation’s largest health insurance company.

Anthem’s $54 billion purchase of Cigna still needs approval of federal regulators. Groups representing medical care providers like the American Medical Association and the American Hospital Association have already urged the U.S. Justice Department to closely scrutinize the deal.

The Anthem and Cigna marriage comes amid unprecedented consolidation in the healthcare industry and among health plans in particular. This summer, Aetna (AET) announced plans to buy rival Humana (HUM) for nearly $40 billion. And while Aetna and Humana shareholders signed off on that deal less than two months ago, it has yet to be cleared by antitrust regulators either.

Anthem’s acquisition of Cigna would create a behemoth with 53 million health plan members under the combined larger company’s umbrella. Anthem operates Blue Cross and Blue Shield plans in 14 states and would add membership from Cigna in those states but would be forced to market under a different brand outside of those regions because other insurers have the Blue Cross and Blue Shield Association license in other states.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Haemonetics Wins FDA Approval for Vascade MVP XL System

Haemonetics has secured an expanded regulatory milestone in the...

FDA Clears Medtronic Stealth Axis for Cranial, ENT Uses

Medtronic’s Stealth Axis FDA clearance marks an expansion of...

Philips AI DeviceGuide Gets FDA Approval for Cardiac Use

Regulatory clearance has been secured by Philips from the...

GE HealthCare Drives Cardio-Oncology Care in EU COMPASS

GE HealthCare has taken on the role of lead...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »